READ & SUCCEED

GOOD NEWS

KICKOFF MINISTRY

NEWS: ISS National Lab-Sponsored Research Aims to Improve Cancer Treatments, Muscle Health, and Regenerative Medicine

World news 06dc44fbb4fe5001
Northrop Grumman's Cygnus XL cargo spacecraft berthed to the International Space Station earlier this year.

CAPE CANAVERAL, FL — Researchers are utilizing the unique microgravity environment aboard the International Space Station (ISS) to advance biomedical research aimed at improving cancer treatments, muscle health, and regenerative medicine. The upcoming Northrop Grumman CRS-25 mission will carry multiple investigations sponsored by the ISS National Laboratory, including studies on FDA-approved drugs for age-related muscle loss, novel cancer therapeutics, and the maturation of bioprinted liver tissue. These projects seek to leverage space conditions to better understand cell and tissue behavior, which is difficult to replicate on Earth, potentially accelerating medical discoveries and enhancing patient outcomes.

Among the investigations, the Palo Alto Veterans Institute for Research and Stanford University will screen drugs to address sarcopenia, while Redpoint Oncology will study antibody-drug conjugates using patient-derived tumor organoids grown in microgravity. The Wake Forest Institute for Regenerative Medicine will examine 3D bioprinted liver tissue maturation in space. Nikon will also conduct experiments on engineered cardiac tissue and kidney spheroid drug response. These diverse studies demonstrate how the ISS National Lab supports innovative research to tackle pressing medical challenges.

CREDIT: International Space Station National Laboratory
Original release on GlobeNewswire

ADVERTISEMENT